{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:27:40Z","timestamp":1790447260500,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2524,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1469-0691.2007.01852.x","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T12:29:04Z","timestamp":1202473744000},"page":"198-202","source":"Crossref","is-referenced-by-count":112,"special_numbering":"S1","title":["Other antimicrobials of interest in the era of extended-spectrum \u03b2-lactamases: fosfomycin, nitrofurantoin and tigecycline"],"prefix":"10.1016","volume":"14","author":[{"given":"J.","family":"Garau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01852.x_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/429344","article-title":"Burden of community-onset Escherichia coli bacteremia in seniors","volume":"191","author":"Jackson","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib3","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1128\/AAC.44.10.2728-2732.2000","article-title":"Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues","volume":"44","author":"Frossard","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3171\/jns.2003.98.5.1040","article-title":"Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy","volume":"98","author":"Pfausler","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/24.5.657","article-title":"An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions","volume":"24","author":"Inouye","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib6","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000472870","article-title":"Monuril and modification of pathogenicity traits in resistant microorganisms","volume":"13","author":"Li Pira","year":"1987","journal-title":"Eur Urol"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jac\/dkl315","article-title":"Mutators among CTX-M beta-lactamase-producing Escherichia coli and the risk for the emergence of fosfomycin resistance","volume":"58","author":"Ellington","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1157\/13095372","article-title":"Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae","volume":"24","author":"de Cueto","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijantimicag.2006.05.019","article-title":"Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections","volume":"28S","author":"Mazzei","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib11","first-page":"189","article-title":"How to select a drug for the treatment of bacteriuria in pregnancy","volume":"6","author":"Novelli","year":"1990","journal-title":"New Trends Gynecol Obstet"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diagmicrobio.2006.11.015","article-title":"In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood","volume":"58","author":"Soo","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib13","series-title":"Principles and practice of infectious diseases","first-page":"473","article-title":"Urinary tract agents: nitrofurantoin and methenamine","author":"Hooper","year":"2005"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2006.02.009","article-title":"Antibiotic resistance in Escherichia coli outpatients urinary tract infection isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (Nautica)","volume":"27","author":"Zhanel","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.patbio.2006.07.016","article-title":"Quelle sensibilit\u00e9 aux antibiotiques pour les bact\u00e9ries responsables d'infections urinaires? Que penser de fosfomycine et nitrofuranes?","volume":"54","author":"Honderlick","year":"2006","journal-title":"Pathol Biol"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2005.08.018","article-title":"In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended spectrum beta-lactamase-producing clinical isolates of Escherichia coli","volume":"54","author":"Puerto","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib17","doi-asserted-by":"crossref","unstructured":"Gales AC, Sader HS, Jones RN, SENTRY participants group (Latin America). Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997\u20132000).","DOI":"10.1111\/j.1469-0691.1999.tb00177.x"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/joc.2005.17.3.251","article-title":"Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infection isolated in a multicenter Italian survey: possible impact in guidelines","volume":"17","author":"Fadda","year":"2005","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1309\/BWQKWB2WN6W5X1CC","article-title":"Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae","volume":"120","author":"Procop","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijantimicag.2004.11.006","article-title":"Tigecycline: clinical evidence and formulary positioning","volume":"25","author":"Nathwani","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1128\/AAC.49.4.1636-1638.2005","article-title":"Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline","volume":"49","author":"Fluit","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib22","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1128\/AAC.48.6.2179-2184.2004","article-title":"Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936)","volume":"48","author":"Hirata","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib23","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/AAC.00155-06","article-title":"Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline","volume":"50","author":"Morosini","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib24","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/jac\/dkl414","article-title":"Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England","volume":"58","author":"Hope","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/jac\/dkl008","article-title":"Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study","volume":"57","author":"Galatti","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01852.x_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrumbeta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1460495X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1460495X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:46:33Z","timestamp":1557258393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1460495X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":26,"alternative-id":["S1198743X1460495X"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01852.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}